Keyword: Press release

This page displays contents related to the keyword.

Great Diversity of Wasps Discovered in Africa – Doctoral Candidate Collected over 100,000 Parasitoid Wasps in the Tropical Forest of Uganda (Dissertation Defence: MSc Tapani Hopkins, 27 Feb 2021, Biology)

Doctoral Candidate Tapani Hopkins collected over 100,000 parasitoid wasps from the tropical forest of Uganda during his doctoral dissertation. Current results suggest that there is a diverse parasitoid wasp fauna still awaiting discovery in tropical Africa. His dissertation defence on rhyssine wasp species, their ecology, and how their diversity compares to Amazonia will be held online. Questions are welcome after the event.

A Novel Folic Acid Linked Drug Has Shown to Attenuate Inflammation and Disease Activity in Animal Model of Multiple Sclerosis

01.02.2021

Recently published research has indicated that folate receptor targeting therapy constrains inflammation in inflammatory demyelinating central nervous system lesions and may inhibit progression of the disease in animal model of multiple sclerosis (MS). This research has been conducted in co-operation with Turku PET Centre, Purdue University and Endocyte Inc (now part of Novartis Institutes for BioMedical Research, NIBR).

Scientists Believe Studies by Colleagues Are More Prone to Biases than Their Own Studies

03.02.2021

The properties of human mind affect the quality of scientific knowledge through the insertion of unconscious cognitive biases. Scientists from the University of Turku, Finland, have found that the current level of awareness about research biases is generally low among ecology scientists. Underestimation of the risks associated with unconscious cognitive biases prevents avoiding these risks in a scientist’s own research. Due to unconscious origin of biases, it is impossible to combat them without external intervention.

Novel Therapy-resistance Mechanism Promoting the Growth of Breast Cancer Brain Metastasis

29.01.2021

SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska’s research group at Turku Bioscience observed that SORLA functionally contributes to the most reported therapy-resistant mechanism by which the cell-surface receptor HER3 counteracts HER2 targeting therapy in HER2-positive cancers. Removing SORLA from cancer cells sensitised anti-HER2 resistant breast cancer brain metastasis to targeted therapy.